These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 25884510)

  • 1. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
    Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
    BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors.
    Grum-Schwensen B; Klingelhöfer J; Grigorian M; Almholt K; Nielsen BS; Lukanidin E; Ambartsumian N
    Cancer Res; 2010 Feb; 70(3):936-47. PubMed ID: 20103644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin.
    Švec X; Štorkánová H; Trinh-Minh T; Tran MC; Štorkánová L; Hulejová H; Oreská S; Heřmánková B; Bečvář R; Pavelka K; Vencovský J; Klingelhöfer J; Hussain RI; Hallén J; Šenolt L; Distler JHW; Tomčík M
    Rheumatology (Oxford); 2024 Mar; 63(3):817-825. PubMed ID: 37314987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.
    Klingelhöfer J; Grum-Schwensen B; Beck MK; Knudsen RS; Grigorian M; Lukanidin E; Ambartsumian N
    Neoplasia; 2012 Dec; 14(12):1260-8. PubMed ID: 23308057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
    Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.
    Lu S; Zhang J; Liu D; Li G; Staveley-O'Carroll KF; Li Z; Wu JD
    Clin Cancer Res; 2015 Nov; 21(21):4819-30. PubMed ID: 26106076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.
    O'Connell JT; Sugimoto H; Cooke VG; MacDonald BA; Mehta AI; LeBleu VS; Dewar R; Rocha RM; Brentani RR; Resnick MB; Neilson EG; Zeisberg M; Kalluri R
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16002-7. PubMed ID: 21911392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
    Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
    Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model.
    Shi Y; Zou M; Collison K; Baitei EY; Al-Makhalafi Z; Farid NR; Al-Mohanna FA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2373-9. PubMed ID: 16551737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties.
    Bettum IJ; Vasiliauskaite K; Nygaard V; Clancy T; Pettersen SJ; Tenstad E; Mælandsmo GM; Prasmickaite L
    Cancer Lett; 2014 Mar; 344(1):28-39. PubMed ID: 24215866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes.
    Wang G; Zhang S; Fernig DG; Martin-Fernandez M; Rudland PS; Barraclough R
    Oncogene; 2005 Feb; 24(8):1445-54. PubMed ID: 15608682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice.
    Forst B; Hansen MT; Klingelhöfer J; Møller HD; Nielsen GH; Grum-Schwensen B; Ambartsumian N; Lukanidin E; Grigorian M
    PLoS One; 2010 Apr; 5(4):e10374. PubMed ID: 20442771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells.
    Yu LJ; Li Y; Li C; Li H; Wu ML; Liu ZL; Kong QY; Chen XY; Liu XY; An LJ; Liu J
    Cancer Biomark; 2014; 14(5):325-33. PubMed ID: 25171474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
    Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
    Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway.
    Yang W; Nam K; Ju JH; Lee KM; Oh S; Shin I
    Cell Signal; 2014 Oct; 26(10):2096-106. PubMed ID: 24975844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies.
    Huang A; Peng D; Guo H; Ben Y; Zuo X; Wu F; Yang X; Teng F; Li Z; Qian X; Qin FX
    Sci Rep; 2017 Feb; 7():42687. PubMed ID: 28202921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene.
    Grum-Schwensen B; Klingelhofer J; Berg CH; El-Naaman C; Grigorian M; Lukanidin E; Ambartsumian N
    Cancer Res; 2005 May; 65(9):3772-80. PubMed ID: 15867373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
    Wang L; Wang X; Liang Y; Diao X; Chen Q
    Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clever-1/stabilin-1 controls cancer growth and metastasis.
    Karikoski M; Marttila-Ichihara F; Elima K; Rantakari P; Hollmén M; Kelkka T; Gerke H; Huovinen V; Irjala H; Holmdahl R; Salmi M; Jalkanen S
    Clin Cancer Res; 2014 Dec; 20(24):6452-64. PubMed ID: 25320356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.